Total results with these characteristics: 1411
- Confirmation of Japanese Encephalitis as an Endemic Human Disease Through Sentinel Surveillance in Indonesia
Japanese encephalitis (JE) results in significant mortality and disability in children in Asia. In Indonesia, despite recognition of JE virus transmission, reports of human disease have been few and from limited geographic areas. Hospital-based …
Author: Ompusunggu S, Hills S, Sembiring Maha M, et al.
- Conjugate Vaccine Introduction in the African Meningitis Belt: Meeting Surveillance Objectives
This article, published in Tropical Medicine & International Health, asserts that surveillance systems and techniques for diagnosing bacterial meningitis and pneumococcal disease in the African meningitis belt have improved greatly over the …
Author: Mueller JE
- Conjugate Vaccines
This review, published in Expert Review of Vaccines, looks at what has been learned from developing conjugate vaccines against Haemophilus influenzae type b, Streptococcus pneumoniae, and group C Neisseria meningitidis that could be useful for the …
Author: Lockhart S
- Conjugate Vaccines and the Carriage of Haemophilus influenzae type b
Many junior doctors today have not had occasion to treat a child for Hib disease. The remarkable absence of cases of this disease is due to the use of conjugate vaccines. In countries with established Hib vaccination programs the incidence of …
Author: Barbour M
- Continuing Increases in Autism Reported to California's Developmental Services System
This study, published in the journal Archives of General Psychiatry, evaluates the rates of autism in California following the discontinued use of thimerosal in childhood vaccines. ABSTRACT ONLY. (Learn how users in developing countries …
Author: Schechter R, Grether J
- The Contribution of Specific Pneumococcal Serogroups to Different Disease Manifestations: Implications for Conjugate Vaccine Formulation and Use, Part II
To assess whether certain serogroups of Streptococcus pneumoniae are preferentially associated with specific disease manifestations, we analyzed all recent pneumococcal disease studies and assessed the relative frequency of isolation of each …
Author: Hausdorff WP, Bryant J, Paradiso P, Siber G
- Control of Epidemic Meningococcal Disease. WHO Practical Guidelines. 2nd Edition
These guidelines, designed for physicians, laboratory workers, and health care administrators, provide comprehensive information on epidemiology and standard techniques for diagnosis, treatment, prevention, and control of meningococcal disease …
Author: World Health Organization
- Control of Japanese Encephalitis--Within Our Grasp?
The article, from the New England Journal of Medicine, provides an up-to-date summary of JE disease incidence, epidemiology, and vaccines against JE.
Author: Solomon T
- Cool Innovations for Vaccine Transportation and Storage
Keeping heat-sensitive vaccines and other drugs at the right temperature is crucial yet often difficult in areas with limited or no electrical power. This fact sheet describes a response to this challenge, where a group of public- and private-sector …
Author: PATH, World Health Organization
- Coordinated Surveillance and Detection of Pneumococcal and Haemophilus influenzae type b (Hib) Disease in Developing Countries
This supplemental issue of Clinical Infectious Diseases provides numerous articles on the surveillance and detection of pneumococcal and Haemophilus influenzae type b disease in developing countries. Topics include progress and challenges in disease …
Author: Black S, Knoll MD, eds.
- The Cornerstone of Public Health
This fact sheet makes the case for why vaccines are a critical, cost-effective investment for improving global health and saving children's lives.
- Correlates of Protection: Novel Generations of Influenza Vaccines
This article, published in the journal Vaccine, reviews potential correlates of protection against influenza and discusses some of the vaccination strategies that could result in optimal protection against epidemic and pandemic influenza. ABSTRACT …
Author: Rimmelzwaan GF, McElhaney JE
- Cost and Effectiveness Analysis of Immunization Service Delivery Support in Andhra Pradesh, India
Published in the Bulletin of the World Health Organization, this paper offers the first attempt to quantitatively evaluate the supportive supervision framework in Andhra Pradesh, India.
Author: Suraratdecha C, Ramana V, Kaipilyawar S, et al.
- The Cost and Public Health Burden of Invasive Meningococcal Disease Outbreaks: A Systematic Review
Invasive meningococcal disease (IMD) is a serious disease with a rapid onset, high mortality rate, and risk of long-term complications. The authors of this article, published in Pharmacoeconomics, systematically reviewed the literature on the costs …
Author: Anonychuk A, Woo G, Vyse A, Demarteau N, Tricco AC
- A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison Between Rotarix and RotaTeq Vaccines
The authors of this article, published in PLoS ONE, applied cost-effectiveness modeling and a cold-chain impact assessment to aid decision-making on rotavirus vaccine introduction in Kenya. They conclude that use of either vaccine is cost-effective, …
Author: van Hoek AJ, Ngama M, Ismail A, et al.
- Cost Effectiveness of Rotavirus Vaccines and Other Interventions for Diarrhoeal Diseases: Meeting Report 2006
This report from the WHO's Weekly Epidemiologic Record summarizes a meeting convened by PATH, WHO, and the US Centers for Disease Control and Prevention (CDC) on the economic burden of rotavirus disease and cost-effectiveness of vaccines. The …
Author: World Health Organization
- A Cost Function Analysis of Shigellosis in Thailand
This article, published in Value in Health, discusses a study to develop a cost function model to estimate the public treatment cost of shigellosis patients in Thailand. The study was an incidence-based cost-of-illness …
Author: Riewpaiboon A, Youngkong S, Sreshthaputra N, et al.
- The Cost of Immunization Programs in the Next 10 Years
This paper summarizes the results of a WHO/UNICEF study on the potential impact of immunization over the next decade and the financing required for immunization activities in the 72 poorest countries of the world.
Author: World Health Organization
- The Cost of Unsafe Injections
Unsafe injection practices are associated with substantial morbidity and mortality. Annually more than 1.3 million deaths and US$535 million in expenses are estimated to be due to unsafe injection practices. This article, published in the Bulletin …
Author: Miller MA, Pisani E
- Cost-Effectiveness and Economic Benefits of Vaccines in Low- and Middle-Income Countries: A Systematic Review
This review, published in Vaccine, documents the available evidence showing that vaccination in low- and middle-income countries brings important economic benefits. The cost-effectiveness studies reviewed suggest to policy makers that vaccines are …
Author: Ozawa S, Mirelman A, Stack ML, Walker DG, Levine OS
- Cost-Effectiveness and Potential Impact of Rotavirus Vaccination in the United States
This study, published in the journal Pediatrics, examines the costs and benefits of routine rotavirus vaccination for infants in the US, using a hypothetical cohort of unvaccinated infants. Researchers determined that, at current prices, …
Author: Widdowson MA, Meltzer MI, Zhang X, et al.
- Cost-Effectiveness of Childhood Rotavirus Vaccination in Taiwan
This paper, published in the journal Vaccine, investigates whether routine infant immunization with either currently licensed rotavirus vaccine could be cost-effective in Taiwan. The authors modeled specific disease outcomes …
Author: Wu CL, Yang YC, Huang LM, Chen KT
- Cost-effectiveness of Conjugate Meningococcal Vaccination Strategies in the United States
This article, published in the journal Pediatrics, discusses a study to evaluate and compare the projected health and economic impact of meningococcal conjugate A/C/Y/W-135 (MCV-4) vaccination of adolescents, toddlers, and infants in the United …
Author: Shepard CW, Ortega-Sanchez IR, Scott RD 2nd, Rosenstein NE; ABCs Team
- Cost-Effectiveness of Introducing a Rotavirus Vaccine in Developing Countries: The Case of Mexico
This study, published in BMC Infectious Diseases, developed a model to compare the cost and disease burden of rotavirus in unvaccinated children in Mexico. The study determined that it would be highly cost-effective to include rotavirus vaccine …
Author: Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R
- Cost-Effectiveness of Japanese Encephalitis Vaccination
This fact sheet summarizes methods and results of cost-effectiveness analyses performed by PATH and its partners to determine the economic implications of introducing JE vaccine programs. The fact sheet is an excerpt from a larger, comprehensive …